A. Krämer

1.5k total citations
31 papers, 723 citations indexed

About

A. Krämer is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, A. Krämer has authored 31 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 7 papers in Hematology. Recurrent topics in A. Krämer's work include Cancer Diagnosis and Treatment (12 papers), Tumors and Oncological Cases (7 papers) and Cancer-related Molecular Pathways (6 papers). A. Krämer is often cited by papers focused on Cancer Diagnosis and Treatment (12 papers), Tumors and Oncological Cases (7 papers) and Cancer-related Molecular Pathways (6 papers). A. Krämer collaborates with scholars based in Germany, Australia and United States. A. Krämer's co-authors include Kai Neben, AD Ho, Tilmann Bochtler, Andreas Willer, Ute Hegenbart, R Hehlmann, H. Löffler, Anthony D. Ho, Axel Benner and Hartmut Goldschmidt and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Annals of Oncology.

In The Last Decade

A. Krämer

29 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Krämer Germany 14 323 251 229 185 123 31 723
Angela Hamblin United Kingdom 11 288 0.9× 179 0.7× 207 0.9× 59 0.3× 96 0.8× 32 708
Jan‐Henrik Mikesch Germany 15 330 1.0× 212 0.8× 194 0.8× 46 0.2× 42 0.3× 54 680
W.‐K. Hofmann Germany 15 248 0.8× 110 0.4× 194 0.8× 85 0.5× 63 0.5× 22 905
Ivana von Metzler Germany 17 594 1.8× 467 1.9× 350 1.5× 40 0.2× 117 1.0× 31 951
Ugo Consoli Italy 17 367 1.1× 395 1.6× 257 1.1× 22 0.1× 102 0.8× 36 863
Yingzhe Yu China 9 195 0.6× 189 0.8× 195 0.9× 22 0.1× 79 0.6× 23 626
Thai M. Cao United States 17 164 0.5× 296 1.2× 379 1.7× 28 0.2× 149 1.2× 48 866
Junichi Ueyama Japan 11 162 0.5× 171 0.7× 204 0.9× 28 0.2× 52 0.4× 35 545
Yuji Shimura Japan 15 357 1.1× 226 0.9× 227 1.0× 25 0.1× 199 1.6× 69 704
Yukiko Komeno Japan 20 549 1.7× 112 0.4× 445 1.9× 34 0.2× 40 0.3× 44 984

Countries citing papers authored by A. Krämer

Since Specialization
Citations

This map shows the geographic impact of A. Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Krämer more than expected).

Fields of papers citing papers by A. Krämer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Krämer. The network helps show where A. Krämer may publish in the future.

Co-authorship network of co-authors of A. Krämer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Krämer. A scholar is included among the top collaborators of A. Krämer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Krämer. A. Krämer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Westphalen, C. Benedikt, Chantal Pauli, Nasséra Chalabi, et al.. (2023). Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study. ESMO Open. 8(6). 102035–102035. 7 indexed citations
3.
Westphalen, C. Benedikt, Andreas Beringer, Tilmann Bochtler, et al.. (2021). 1804P Baseline mutational profiles of patients (pts) with carcinoma-of-unknown-primary-origin (CUP) enrolled onto CUPISCO. Annals of Oncology. 32. S1227–S1228.
4.
Mileshkin, Linda, Tilmann Bochtler, Andreas Beringer, et al.. (2020). 519P Patterns of care and outcomes in carcinoma of unknown primary: A SEER-Medicare study. Annals of Oncology. 31. S459–S459. 2 indexed citations
5.
Krämer, A., et al.. (2020). Development of a Hematology-Oncology Advanced Practice Provider Fellowship Program. Journal of the Advanced Practitioner in Oncology. 11(4). 407–410. 5 indexed citations
7.
Pauli, Chantal, Tilmann Bochtler, Linda Mileshkin, et al.. (2019). A challenging task – Identifying carcinoma of unknown primary (CUP) patients according to ESMO guidelines: The CUPISCO trial experience. Annals of Oncology. 30. v813–v814. 3 indexed citations
9.
Bochtler, Tilmann, Stefan Fröhling, & A. Krämer. (2015). Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia. Leukemia. 29(6). 1243–1252. 29 indexed citations
10.
Löffler, H., Kai Neben, & A. Krämer. (2014). CUP-Syndrom. Der Radiologe. 54(2). 107–111. 6 indexed citations
11.
Löffler, H., Kai Neben, & A. Krämer. (2014). Strukturierte Diagnostik und internistische Therapie des CUP-Syndroms. Der Radiologe. 54(2). 112–116. 1 indexed citations
12.
Bochtler, Tilmann, Michael Kirsch, Bettina Maier, et al.. (2011). Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disorders. Leukemia. 26(4). 728–735. 8 indexed citations
13.
Krämer, A.. (2005). Centrosome aberrations – hen or egg in cancer initiation and progression?. Leukemia. 19(7). 1142–1144. 25 indexed citations
14.
Krämer, A., Kai Neben, Jörg Kalla, et al.. (2003). Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma. Leukemia. 17(11). 2207–2213. 60 indexed citations
15.
Krämer, A., Kai Neben, & AD Ho. (2002). Centrosome replication, genomic instability and cancer. Leukemia. 16(5). 767–775. 117 indexed citations
16.
Roß, R. Stefan, et al.. (2002). Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay. Journal of Virological Methods. 101(1-2). 159–168. 47 indexed citations
17.
Krämer, A., Beate Schultheis, Jean‐François Bergmann, et al.. (2002). Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myeloma. Leukemia. 16(9). 1844–1851. 50 indexed citations
18.
Krämer, A., H. Löffler, Jean‐François Bergmann, Andreas Hochhaus, & Rüdiger Hehlmann. (2001). Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia. Leukemia. 15(1). 62–68. 13 indexed citations
19.
Schultheis, Beate, A. Krämer, Andreas Willer, et al.. (1999). Analysis of p73 and p53 gene deletions in multiple myeloma. Leukemia. 13(12). 2099–2103. 24 indexed citations
20.
Möhle, Robert, et al.. (1994). Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesis.. PubMed. 14(5). 827–32. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026